Serum neurofilament light chain as a presymptomatic biomarker in multiple sclerosis

被引:0
|
作者
Bjornevik, K. [1 ]
Munger, K. L. [1 ]
Cortese, M. [1 ]
Barro, C. [2 ]
Healy, B. C. [3 ]
Niebuhr, D. W. [4 ]
Scher, A. I. [4 ]
Kuhle, J. [2 ]
Ascherio, A. [1 ,5 ,6 ]
机构
[1] Harvard TH Chan Sch Publ Hlth, Boston, MA USA
[2] Univ Basel, Univ Hosp Basel, Basel, Switzerland
[3] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[4] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
[5] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA
[6] Harvard Med Sch, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
284
引用
收藏
页码:108 / 109
页数:2
相关论文
共 50 条
  • [31] Serum neurofilament light chain as a biomarker for acute and chronic neuronal damage in early relapsing-remitting multiple sclerosis
    Siller, N.
    Kuhle, J.
    Uphaus, T.
    Barro, C.
    Muthuraman, M.
    Kappos, L.
    Groppa, S.
    Zipp, F.
    Bittner, S.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 300 - 300
  • [32] Serum Neurofilament Light Chain Levels as a Biomarker of Disease Activity and Treatment Response in Patients with Progressive and Relapsing Multiple Sclerosis
    Pedrini, Marzena
    Kaskow, Belinda
    Trend, Stephanie
    Carroll, William
    Walters, Susan
    Maceski, Aleksandra
    Kuhle, Jens
    Kermode, Allan
    [J]. NEUROLOGY, 2023, 100 (17)
  • [33] Neurofilament light chain A prognostic biomarker in amyotrophic lateral sclerosis
    Berger, Thomas
    Stueve, Olaf
    [J]. NEUROLOGY, 2019, 92 (10) : 451 - 452
  • [34] Neurofilament light chain A prognostic biomarker in amyotrophic lateral sclerosis
    Lu, Ching-Hua
    Macdonald-Wallis, Corrie
    Gray, Elizabeth
    Pearce, Neil
    Petzold, Axel
    Norgren, Niklas
    Giovannoni, Gavin
    Fratta, Pietro
    Sidle, Katie
    Fish, Mark
    Orrell, Richard
    Howard, Robin
    Talbot, Kevin
    Greensmith, Linda
    Kuhle, Jens
    Turner, Martin R.
    Malaspina, Andrea
    [J]. NEUROLOGY, 2015, 84 (22) : 2247 - 2257
  • [35] Neurofilament light chain in the assessment of patients with multiple sclerosis
    Domingues, Renan Barros
    Peres Fernandes, Gustavo Bruniera
    Vilela de Moura Leite, Fernando Brunale
    Senne, Carlos
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2019, 77 (06) : 436 - 441
  • [36] Serum Neurofilament Light Chain and Glial Fibrillary Acid Protein in Patients With Multiple Sclerosis
    Ayrignac, Xavier
    Maceski, Aleksandra Maleska
    Carra-Dalliere, Clarisse
    Charif, Mahmoud
    Catteau, Cyndi
    Ginestet, Nelly
    Prin, Pauline
    Corti, Lucas
    Pinna, Frederic
    Lehmann, Sylvain
    Labauge, Pierre
    [J]. NEUROLOGY, 2019, 92 (15)
  • [37] Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management
    Freedman, Mark S.
    Gnanapavan, Sharmilee
    Booth, Ronald A.
    Calabresi, Peter A.
    Khalil, Michael
    Kuhle, Jens
    Lycke, Jan
    Olsson, Tomas
    [J]. EBIOMEDICINE, 2024, 101
  • [38] Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis
    Thebault, Simon
    Abdoli, Mohammad
    Fereshtehnejad, Seyed-Mohammad
    Tessier, Daniel
    Tabard-Cossa, Vincent
    Freedman, Mark S.
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [39] From Mouse to Man - Translational Aspects of Serum Neurofilament Light Chain in Multiple Sclerosis
    Zipp, Frauke
    Steffen, Falk
    Piepgras, Johannes
    Fleischer, Vinzenz
    Luessi, Felix
    Groppa, Sergiu
    Bittner, Stefan
    [J]. NEUROLOGY, 2019, 92 (15)
  • [40] Renal function influences serum neurofilament light chain levels in patients with multiple sclerosis
    Gasque Rubio, R.
    Cubas Nunez, L.
    Castillo Villalba, J.
    Carratala Bosca, S.
    Alcala, C.
    Perez Miralles, F.
    Quintanilla Bordas, C.
    Laiz Marro, B.
    Casanova Estruch, B.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 585 - 585